Finance

Senarai
300562:SHE
Guangdong Transtek Medicl Elctrncs CoLtd
CN¥14.38
+0.14%
(+0.020) 1H
13 Okt, 3:04:22 PTG GMT+8  ·   CNY
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk 300562...
Buka
CN¥14.20
Tinggi
CN¥14.52
Rendah
CN¥13.53
Permodalan Pasaran
3.29B
Purata volum
17.24J
Volum
11.71J
Dividen
1.81%
Dividen suku tahunan
CN¥0.06
Tarikh tanpa dividen
15 Okt 2026
Nisbah H/P
31.49
tgi 52 mgu
CN¥19.54
rdh 52 mgu
CN¥11.32
EPS
CN¥0.46
Syer tertunggak
218.93J
Bilangan pekerja
1K
Buka
CN¥14.20
Tinggi
CN¥14.52
Rendah
CN¥13.53
Permodalan Pasaran
3.29B
Purata volum
17.24J
Volum
11.71J
Dividen
1.81%
Dividen suku tahunan
CN¥0.06
Tarikh tanpa dividen
15 Okt 2026
Nisbah H/P
31.49
tgi 52 mgu
CN¥19.54
rdh 52 mgu
CN¥11.32
EPS
CN¥0.46
Syer tertunggak
218.93J
Bilangan pekerja
1K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Profil
Transtek Medical, commonly known as Lifesense, fully referred to as Guangdong Transtek Medical Electronics Co., Ltd., is a Chinese wearable device maker that also focuses on the field of mobile health. The company was founded by Weichao Pan in 2002, with its main products being home medical and health electronics, such as scales, smart bracelets and blood pressure monitors. According to IDC, the company shipped one million units of wearables in the second quarter of 2016, ranking fifth in the global wearable devices market, coming in behind Fitbit, Apple and Garmin. Transtek's IPO application was approved by the CSRC in October 2016. On November 16, it landed on the Shenzhen Stock Exchange with the ticker symbol "300562.SZ". Wikipedia
Perihal Guangdong Transtek Medicl Elctrncs CoLtd
CEO-
Pekerja1.09K
Diasaskan18 Jul 2002
Ibu pejabat-
Sektor-
Laman weblifesense.com
Laporan sebelumnyaSemua nilai dalam CNY
Loading Previous Earnings...
Hasil
Pendapatan bersih
Semua nilai dalam CNY
Sep 2025
Dis 2025
Mac 2026
Jun 2026
Hasil
235.76J
229.08J
283.74J
250.69J
Kos barangan yang dijual
149.14J
152.94J
176.58J
166.11J
Kos hasil
149.14J
152.94J
176.58J
166.11J
Perbelanjaan penyelidikan dan pembangunan
20.36J
24.79J
26.69J
23.33J
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
41.57J
26.45J
41.12J
21.85J
Belanja kendalian
58.96J
52.61J
71.19J
48.25J
Jumlah belanja kendalian
208.10J
205.55J
247.78J
214.35J
Pendapatan kendalian
27.66J
23.53J
35.96J
36.34J
Pendapatan bukan kendalian lain
-3.39J
2.22J
-4.58J
3.96J
EBT termasuk item luar biasa
23.63J
16.59J
32.82J
31.28J
EBT tidak termasuk item luar biasa
25.70J
24.73J
31.68J
34.21J
Belanja cukai pendapatan
118.51K
1.08J
931.10K
3.84J
Kadar cukai berkesan
0.50%
6.54%
2.84%
12.27%
Belanja kendalian lain
-1.92J
3.87J
1.19J
2.80J
Pendapatan bersih
23.39J
16.32J
32.07J
27.96J
Margin untung bersih
9.92%
7.12%
11.30%
11.15%
Perolehan bagi setiap syer
-
-
-
-
Pendapatan faedah dan pelaburan
3.39J
2.85J
330.33K
3.10J
Belanja faedah
-1.40J
-
-37.02K
-57.71K
Belanja faedah bersih
1.99J
2.85J
293.32K
3.05J
Caj susut nilai dan pelunasan
-
-
-
-
EBITDA
32.45J
28.29J
40.73J
41.00J
Keuntungan atau kerugian daripada jualan aset
-150.13K
26.11K
-
-1.36J
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian
Apl Google